{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:13:12Z","timestamp":1761520392906,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clcc.2022.03.006","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T11:43:08Z","timestamp":1654515788000},"page":"e226-e231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cure Rates According to Dose-Intensity of Chemoradiation in T2N0 Squamous Cell Carcinoma of the Anal Canal"],"prefix":"10.1016","volume":"21","author":[{"given":"Iara K.F.","family":"Lustosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-8196","authenticated-orcid":false,"given":"Marcos P.G.","family":"Camandaroba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna R.S.","family":"Mattos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silmara F.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Iseas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel P.","family":"Riechelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2022.03.006_bib0001","article-title":"Cancer statistics, 2020","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2022.03.006_bib0002","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clcc.2022.03.006_bib0003","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2022.03.006_bib0004","article-title":"Disease-free survival and time to complete response after definitive chemoradiotherapy for squamous-cell carcinoma of the anus according to HIV infection","author":"Camandaroba","year":"2020","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clcc.2022.03.006_bib0005","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin","author":"Northover","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2022.03.006_bib0006","doi-asserted-by":"crossref","DOI":"10.1097\/DCR.0b013e3182a226bd","article-title":"Predictive factors for early and late local toxicities in anal cancer treated by radiotherapy in combination with or without chemotherapy","author":"Doyen","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2022.03.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2013.05.037","article-title":"Faecal incontinence after chemoradiotherapy in anal cancer survivors: long-term results of a national cohort","author":"Bentzen","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2022.03.006_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/S0360-3016(03)00417-6","article-title":"Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal","author":"Deniaud-Alexandre","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clcc.2022.03.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2011.09.015","article-title":"Node-negative T1-T2 anal cancer: radiotherapy alone or concomitant chemoradiotherapy?","author":"Zilli","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clcc.2022.03.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.03.006_bib0011","article-title":"Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European organization for research and treatment of cancer radiotherapy and gastro","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clcc.2022.03.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(05)60945-2","article-title":"Combined radiotherapy and chemotherapy for anal cancer","author":"Northover","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.clcc.2022.03.006_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113248","article-title":"Stage I squamous cell carcinoma of the anus: Is radiation therapy alone sufficient treatment?","author":"Miller","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2022.03.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2021.08.924","article-title":"402P Chemoradiation versus less intensive treatments in stage I squamous cell carcinoma of the anal canal (SCCA)","author":"Riechelmann","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2022.03.006_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092099","article-title":"De-escalation of therapy for patients with early-stage squamous cell carcinoma of the anus","author":"Miller","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clcc.2022.03.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.3577","article-title":"Prospective study of biomarkers in squamous cell carcinoma of the anal canal (SCCAC) and their influence on treatment outcomes: Final results","author":"Moniz","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clcc.2022.03.006_bib0017","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21037\/jgo.2018.10.08","article-title":"Treatment outcomes of patients with localized anal squamous cell carcinoma according to HIV infection: systematic review and meta-analysis","volume":"10","author":"Camandaroba","year":"2018","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2022.03.006_bib0018","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.52.3464","article-title":"Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal","author":"Serup-Hansen","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002822000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:09:21Z","timestamp":1761520161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002822000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1533002822000664"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2022.03.006","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cure Rates According to Dose-Intensity of Chemoradiation in T2N0 Squamous Cell Carcinoma of the Anal Canal","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2022.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}